Company Filing History:
Years Active: 2022
Title: Dagmar Juergens: Innovator in Pain Treatment
Introduction
Dagmar Juergens, an accomplished inventor based in Aachen, Germany, has made significant strides in the field of medical innovation. With a focus on pain management, his work addresses critical conditions that affect many individuals worldwide.
Latest Patents
Juergens holds a patent for "Methods of treating chronic and neuropathic pain mediated by N-type neuronal calcium channels using D-enantiomeric peptides." This invention details a composition that includes peptides such as RD2 and D3, as well as their homologs and derivatives. The patent emphasizes their therapeutic use in alleviating chronic and neuropathic pain by inhibiting N-type neuronal calcium channels, showcasing the potential to transform pain therapy.
Career Highlights
Currently, Dagmar Juergens is affiliated with Forschungszentrum Jülich GmbH, a leading research center in Germany. His role allows him to engage in impactful research, contributing to advancements in clinical pain treatment technologies. His dedication to finding innovative solutions has placed him at the forefront of medical research.
Collaborations
Throughout his career, Juergens has collaborated with notable colleagues, including Dieter Willbold and Janine Kutzsche. These partnerships not only enhance the quality of his research but also expand the network of expertise in the development of effective pain management strategies.
Conclusion
Dagmar Juergens continues to be a significant figure in the realm of innovations for pain treatment. His patented methods potentially offer relief to countless individuals suffering from chronic and neuropathic pain, underscoring the vital role of inventors in addressing complex medical challenges.